{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 3, "transaction_limit": 160, "filters": {"q": "", "ticker": "SNDX", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 3, "acquisition_count": 2, "disposal_count": 1, "acquisition_value": 206552.5, "acquisition_value_label": "$206.6K", "disposal_value": 784776.475, "disposal_value_label": "$784.8K", "net_value": -578223.975, "net_value_label": "$-578.2K", "flow_tone": "negative", "largest_value_label": "$784.8K", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 3, "value": "991328.9750", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$991.3K"}], "days": [{"transaction_date": "2026-07-08", "acquisitions": 2, "disposals": 1, "total": 3, "bar_width": 100.0}], "side_mix": {"acquisitions": 2, "disposals": 1, "acquisition_share": 66.7, "disposal_share": 33.3}}, "company_flows": [{"symbol": "SNDX", "name": "Syndax Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-08", "acquisitions": 2, "disposals": 1, "acquired_value": 206552.5, "acquired_value_label": "$206.6K", "disposed_value": 784776.475, "disposed_value_label": "$784.8K", "net_value": -578223.975, "net_value_label": "$-578.2K", "acquisition_share": 66.7, "disposal_share": 33.3, "detail_url": "https://sharemaestro.com/insider-activity/company/sndx/", "research_links": {"chart": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/", "report": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/report/", "factor": "/factors/ticker/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/"}}], "company_overview": [{"symbol": "SNDX", "name": "Syndax Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-08", "filings": 3, "acquisitions": 2, "disposals": 1, "acquired_value": 206552.5, "acquired_value_label": "$206.6K", "disposed_value": 784776.475, "disposed_value_label": "$784.8K", "net_value": -578223.975, "net_value_label": "$-578.2K", "acquisition_share": 66.7, "disposal_share": 33.3, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/sndx/", "research_links": {"chart": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/", "report": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/report/", "factor": "/factors/ticker/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/"}}], "transactions": [{"symbol": "SNDX", "name": "Syndax Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "METZGER, MICHAEL A", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 32375.0, "share_price": 24.2402, "transaction_value": 784776.475, "fetched_at": "2026-07-29T11:08:17.593492+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/sndx/", "research_links": {"chart": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/", "report": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/report/", "factor": "/factors/ticker/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/"}}, {"symbol": "SNDX", "name": "Syndax Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "METZGER, MICHAEL A", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 32375.0, "share_price": 6.38, "transaction_value": 206552.5, "fetched_at": "2026-07-29T11:08:17.596137+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/sndx/", "research_links": {"chart": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/", "report": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/report/", "factor": "/factors/ticker/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/"}}, {"symbol": "SNDX", "name": "Syndax Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "METZGER, MICHAEL A", "executive_title": "Director, Chief Executive Officer", "security_type": "Stock Option (Right to buy)", "side_code": "A", "side": "Acquisition", "shares": 32375.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-29T11:08:17.589856+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/sndx/", "research_links": {"chart": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/", "report": "/terminal/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/report/", "factor": "/factors/ticker/8d1d1791-96e4-4ced-8f03-56f9a1cd0289/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}